Yüklüyor......

Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy

With the use of nucleoside analogs as frontline therapy, the prognosis of hairy cell leukemia (HCL) has improved dramatically. Unfortunately, disease recurrence remains problematic. Eradication of minimal residual disease (MRD) persisting after therapy may further improve outcome. The evolution of a...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: THOMAS, DEBORAH A., RAVANDI, FARHAD, KEATING, MICHAEL, KANTARJIAN, HAGOP M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC4109291/
https://ncbi.nlm.nih.gov/pubmed/19814695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428190903142224
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!